Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor

Highly Accessed Review

Erosive arthritis

Georg Schett

Arthritis Research & Therapy 2007, 9(Suppl 1):S2  doi:10.1186/ar2166


  • Last 30 days: 61 accesses
  • Last 365 days: 1020 accesses
  • All time: 11694 accesses